Pioglitazone And Glimepiride Tablet
Pricing Report NDC 66993-821-30

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Pioglitazone And Glimepiride (NDC 66993-821-30) is $10.78030 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a a human prescription drug provided by Prasco Laboratories, this medication is distributed in a 30 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$10.78030
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jun 17, 2026
Billable Units
30 EA
Estimated Package Price
$323.41
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
66993-821-30
Description
30 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2015, the NADAC wholesale price for (NDC ) has moved within a range of $7.20222 to $11.30907 per EA. Over this 10 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$7.2022 - $11.3091
Market Volatility
57.02% Variance
Latest Trend
0.19%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $10.78030 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2026 $10.80087 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2026 $10.80087 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2026 $10.80087 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2026 $10.80087 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2026 $10.80087 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2025 $10.52067 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2025 $10.52067 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Aug 20, 2025 $10.52067 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2025 $10.54915 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2025 $10.23204 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2025 $9.84361 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2025 $9.37977 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $9.28499 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2025 $8.69447 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2025 $7.93608 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $7.93608 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2024 $7.69783 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 18, 2024 $7.20222 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 18, 2024 $7.20222 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Aug 21, 2024 $7.20222 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 21, 2016 $11.30907 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 21, 2016 $11.30907 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Oct 07, 2015 $9.09300 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026